Inhibitory peptides of MyD88-dependent signal pathway

摘要

The field of invention is a new inhibitory peptide containing a segment which inhibits the activation of MyD88. The invention comprehends the inhibitory peptide and its application for treatment of disease states connected with excessive activation of the innate immune response.